Details of Drug-Drug Interaction
| Drug General Information (ID: DDIN8OIJRL) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Liotrix | Drug Info | Methyltestosterone | Drug Info | |||||
| Drug Type | Small molecule | Small molecule | |||||||
| Therapeutic Class | Thyroid Drugs | Androgens/Anabolic Steroids | |||||||
| Structure | |||||||||
| Mechanism of Liotrix-Methyltestosterone Interaction (Severity Level: Moderate) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Potentiated the pharmacological effects (Unspecific) Click to Show/Hide Mechanism Graph | |||||||||
| Drug Name | Liotrix | Methyltestosterone | |||||||
| Mechanism | Thyroid hormone | Increase the risk of hyperthyroidism in patients receiving thyroid hormone replacement therapy | |||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Pharmacodynamics | ||||||||
| Factor Description | Enhanced pharmacological effects leading to increased adverse reactions. | ||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | Clinical and laboratory monitoring of thyroid function may be necessary, as may a 25% to 50% reduction in thyroid hormone dosage. | ||||||||
